Evidence map›Paper›PMID 34301233›Full record

ArticleBMC ophthalmology2021

Topography-guided corneal surface laser ablation combined with simultaneous accelerated corneal collagen cross-linking for treatment of keratoconus.

Yu Zhang, Yueguo Chen

Open access · goldAbstract read
In one paragraph

Article in BMC ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Keratoconus: imaging modalities and management.Medical hypothesis, discovery & innovation ophthalmology journal · 2024
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Yu ZhangDepartment of Ophthalmology, Beijing key laboratory of restoration of damaged ocular nerve, Peking University Third Hospital, 49 North Huayuan Road, Haidian District, 100191, Beijing, China.
Yueguo ChenDepartment of Ophthalmology, Beijing key laboratory of restoration of damaged ocular nerve, Peking University Third Hospital, 49 North Huayuan Road, Haidian District, 100191, Beijing, China. chenyueguo@263.net.
Peking University · CNPeking University Third Hospital · CN

Funding

Peking University Third Hospital BYSY2018027Peking University Third Hospital BYSYZD2019002
6 · The paper itself

Abstract

backgroundto study the outcomes of topography-guided customized excimer laser subepithelial ablation combined with accelerated CXL for progressive keratoconus.

methodsThirty-one eyes of 30 patients with progressive keratoconus were included in this prospective study. Topography-guided excimer laser ablation without refractive correction was performed. Simultaneous accelerated collagen cross-linking with ultraviolet light of 30 mW/cm

resultsUDVA improved slightly after surgery (P > 0.05). BSCDVA improved significantly from 0.32 ± 0.20 logMAR to 0.15 ± 0.14 logMAR at postoperative 12 months (P < 0.05). During 12-month follow-ups, there were no significant differences in manifest refraction and corneal keratometry except for maximal keratometry value of the anterior surface (K

conclusionsTopography-guided surface ablation without refractive correction combined with simultaneous accelerated collagen cross-linking provided good stability in refraction and corneal curvature, and also showed significant improvement in BSCDVA, corneal regularity and corneal optical quality.

Indexed as

KeratoconusPhotochemotherapyPhotorefractive KeratectomyCollagenCorneal StromaCorneal TopographyCross-Linking ReagentsHumansPhotosensitizing AgentsProspective StudiesRiboflavinCollagenCross-Linking ReagentsPhotosensitizing AgentsRiboflavinAcceleratedCorneal collagen cross-linkingKeratoconusLaser ablationTopography-guided

Identifiers

PMID34301233
PMCPMC8305492
OpenAlexW3186362436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.